Page last updated: 2024-12-06

ferric sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ferric sulfate: RN given refers to Fe(+3)[3:2] salt) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

iron(3+) sulfate : A compound of iron and sulfate in which the ratio of iron(3+) to sulfate ions is 3:2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24826
CHEBI ID53438
MeSH IDM0083447

Synonyms (55)

Synonym
iron(3+) sulfate
einecs 233-072-9
diiron trisulfate
coquimbite mineral
ferric persulfate
iron sesquisulfate
diiron tris(sulphate)
iron persulfate
iron sulfate (fe2(so4)3)
iron(3+) sulfate, (2:3)
hsdb 6311
ccris 7885
ferric tersulfate
iron tersulfate
iron sulfate (2:3)
ferric sesquisulfate
ferric sulfate
iron(iii) sulfate
10028-22-5
sulfuric acid, iron(3+) salt
iron (iii) sulfate
D08922
ferric sulfate (usp)
CHEBI:53438 ,
iron(iii) sulfate(vi)
4ykq1x5e5y ,
ec 233-072-9
unii-4ykq1x5e5y
FT-0627289
AKOS015903761
ferric sulfate [inci]
ferric sulfate anhydrous
ferric sulfate [mi]
ferric sulfate [who-dd]
iron(iii)sulphate
RUTXIHLAWFEWGM-UHFFFAOYSA-H
mfcd00011007
sulfuric acid,iron salt
DTXSID5029712 ,
Q409021
iron(3+);trisulfate
iron(iii) sulphate hydrate
diiron trissulfate hydrate
iron-s-hydrate
ferric sulfate hydrate 500gm
diiron trissulphate hydrate
ferric sulphate
iron(iii) sulfate (fe2(so4)3)
fe2o12s3
dtxcid409712
stasis
styptic
usepa/opp pesticide code: 034902
amersep 5320
diiron(3+) sulfate

Research Excerpts

Overview

Polyferric sulfate (PFS) is a coagulant widely used for removing contaminants from the aqueous phase. PFS destabilizes and recrystallizes in the solid phase in the presence of dissimilatory iron reducing bacteria (DIRB), which has a profound influence on the cycle of Fe.

ExcerptReferenceRelevance
"Polyferric sulfate (PFS) is a coagulant widely used for removing contaminants from the aqueous phase; however, PFS destabilizes and recrystallizes in the solid phase in the presence of dissimilatory iron reducing bacteria (DIRB), which has a profound influence on the cycle of Fe and the fate of the associated pollutants. "( Biogenic iron mineralization of polyferric sulfate by dissimilatory iron reducing bacteria: Effects of medium composition and electric field stimulation.
Dang, Z; Feng, C; Tang, J; Wang, Q; Wei, Z; Yi, X, 2019
)
1.35
"Ferric sulfate solution is an accepted soft tissue hemostatic agent for use in dermatology and dentistry. "( Ferric sulfate hemostasis: effect on osseous wound healing. Left in situ for maximum exposure.
Jeansonne, BG; Lemon, RR; Steele, PJ, 1993
)
3.17
"Ferric sulfate is an effective hemostatic agent, but with prolonged application to an osseous defect can cause persistent inflammation and delayed healing."( Ferric sulfate hemostasis: effect on osseous wound healing. II. With curettage and irrigation.
Boggs, WS; Jeansonne, BG; Lemon, RR, 1993
)
2.45

Effects

ExcerptReferenceRelevance
"Ferric sulfate has gained significant favor as a result of formocresol's disadvantages, though at the cost of requiring a much more acute awareness of the potential for remaining disease and its ability to mask that process."( Current trends in primary tooth pulp therapy.
Haney, KL, 2007
)
1.06

Toxicity

ExcerptReferenceRelevance
", Management Strategies for Toxic Blue Green Algae: Literature Review."( Assessing drinking water treatment systems for safety against cyanotoxin breakthrough using maximum tolerable values.
Bornmann, K; Imhof, L; Izydorczyk, K; Mankiewicz, J; Schmidt, W, 2008
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
"Attempts were made in this study to examine the efficiency of Fenton process combined with coagulation for treatment of water-based printing ink wastewater."( Treatment of water-based printing ink wastewater by Fenton process combined with coagulation.
Ma, XJ; Xia, HL, 2009
)
0.35
" Moreover, the PFS treatment combined with cross-frequency magnetic field could greatly reduce the pollution of iron ions released from iron-based coagulant during wastewater treatment."( Application of polymeric ferric sulfate combined with cross-frequency magnetic field in the printing and dyeing wastewater treatment.
Gu, S; Lian, F; Yan, K; Zhang, W, 2019
)
0.82

Bioavailability

ExcerptReferenceRelevance
"Effects of coprophagy and coprophagy preventing device on iron bioavailability were evaluated in two experiments."( Effect of coprophagy on bioavailability of iron from plant foods fed to anemic rats.
Hendricks, DG; Mahoney, AW; Zhang, D, 1992
)
0.28
" It was concluded that the FePO4 used to fortify the malted cocoa drink was as well absorbed as FeSO4 but that the high levels of absorption were a reflection of the fasting condition of the subjects."( Iron absorption from a malted cocoa drink fortified with ferric orthophosphate using the stable isotope 58Fe as an extrinsic label.
Fairweather-Tait, SJ; Minski, MJ; Richardson, DP, 1983
)
0.27
" It was concluded that the study design was selective to demonstrate an adequate bioavailability of iron formulations."( [Evaluation of the bioequivalence of two fast-releasing iron(II) sulfate formulations].
Berndt, P; Bührens, KG; Greve, H; Hilgenstock, C; Paschen, U; Vens-Cappell, B, 1993
)
0.29
"Iron depletion-repletion assays were carried out with young chicks to establish Fe bioavailability values for Fe2(SO4)3."( Bioavailability of iron in cottonseed meal, ferric sulfate, and two ferrous sulfate by-products of the galvanizing industry.
Baker, DH; Biehl, RR; Boling, SD; Edwards, HM; Emmert, JL, 1998
)
0.56
" However, fortifying foods with highly bioavailable iron is technically challenging because of off-color and off-flavor development, catalytic degradation of vitamins, and oxidation of lipids."( The role of iron and the factors affecting off-color development of polyphenols.
Li, J; Mehansho, H; Mellican, RI; Nielsen, SS, 2003
)
0.32
" Evaluation of the potential of the amendments as immobilising agents was determined by plant growth (biomass) and elemental accumulation in plant tissues, indicating the bioavailability of As and other heavy metals following amendment."( Remediation of arsenic contaminated soils by iron-oxide application, evaluated in terms of plant productivity, arsenic and phytotoxic metal uptake.
Hartley, W; Lepp, NW, 2008
)
0.35
"Iron bioavailability in obese subjects after the ingestion of a nutritional supplement was the aim of this work."( Iron (FeSo4) bioavailability in obese subjects submitted to bariatric surgery.
Barbosa Junior, F; Bueno, L; Dos Santos, JE; Dutra-de-Oliveira, JE; Marchini, JS; Pizzo, JC,
)
0.13
"Iron bioavailability in obese subjects was affected by the ingestion of the nutritional formulation containing calcium and fiber, a fact that may cause these patients to develop iron deficiency."( Iron (FeSo4) bioavailability in obese subjects submitted to bariatric surgery.
Barbosa Junior, F; Bueno, L; Dos Santos, JE; Dutra-de-Oliveira, JE; Marchini, JS; Pizzo, JC,
)
0.13

Dosage Studied

The efficiency of removal of cellular organic matter (COM) of cyanobacteria Microcystis aeruginosa from water with ferric sulfate is influenced primarily by coagulant dosage and reaction pH. Wooden activated carbon was chosen as adsorbent at the dosage of 10 g/L as a primary treatment, and 1500 mg/L polymeric magnesium ferric sulphate was used in coagulation.

ExcerptRelevanceReference
" Dosing of the input water with ferric sulphate to control external phosphorus loading has occurred since 1983."( The potential for phosphorus release across the sediment-water interface in an eutrophic reservoir dosed with ferric sulphate.
Perkins, RG; Underwood, GJ, 2001
)
0.31
"In order to determine the optimal dosage and type of coagulant for the physico-chemical treatment of leachate from the sanitary landfill of Merida, Mexico, a total of 864 jar tests were performed."( Physico-chemical treatment of Merida landfill leachate for chemical oxygen demand reduction by coagulation.
Castillo-Borges, ER; Giacomán-Vallejos, G; Jiménez-Cisneros, B; Méndez-Novelo, RI; Quintal-Franco, CA; Sauri-Riancho, MR, 2005
)
0.33
" Using a range of different dosage of coagulant, the breakage of flocs was followed at a high stirring speed, corresponding to average shear rate (G) of about 518 s(-1)."( Effect of ozone on the formation and breakup of flocs in raw waters with high algae content.
Gregory, J; O'Halloran, K; Yukselen, MA, 2006
)
0.33
" The optimal dosage with PSF-I is 9 mg x L(-1), in comparison with 12 mg x L(-1) by PSF-I filtrate."( [Analysis of solid-liquid oxidizing poly silicic ferric sulfate (PSF-I)].
Fu, ST; Fu, Y; Yang, YJ; Yu, SL, 2006
)
0.59
" The regulating pH value up to 9 could improve the removal efficiency of Pb(II) up to 95% by coagulation under the optimum dosage of coagulant PFS of 10 mg/L."( [Emergent treatment process for raw water polluted by heavy metal Pb (II)].
Chu, WH; Gao, NY; Qin, ZQ; Shang, YB; Yao, JJ, 2008
)
0.35
"The efficiency of removal of cellular organic matter (COM) of cyanobacteria Microcystis aeruginosa from water with ferric sulfate is influenced primarily by coagulant dosage and reaction pH."( Optimized reaction conditions for removal of cellular organic matter of Microcystis aeruginosa during the destabilization and aggregation process using ferric sulfate in water purification.
Pivokonska, L; Pivokonsky, M; Polasek, P; Tomaskova, H, 2009
)
0.76
" The model was used to optimise FeCl(3) dosing in a real wastewater collection and treatment system."( Iron salts dosage for sulfide control in sewers induces chemical phosphorus removal during wastewater treatment.
Gutierrez, O; Park, D; Sharma, KR; Yuan, Z, 2010
)
0.36
"4%, respectively, however residual COD values were over 200 mg L(-1) even under intensive experimental conditions (high dosage of NaClO and prolonged oxidation time)."( Advanced treatment of the output-stream of biological leachate treatment by appropriate combination of coagulation/flocculation and oxidation.
Donghui, C; Haiying, Z; Hongtao, H; Jingyu, Q; Yi, Z, 2012
)
0.38
" Dosage of the AMD and initial pH of water are the two most important parameters affecting the performance of phosphorus removal of the AMD."( Phosphorus removal performance of acid mine drainage from wastewater.
Bo, L; Lin, Z; Ruihua, L; Tao, T, 2011
)
0.37
" However, residual COD values lower than 200 mg L(-1) could only be achieved under intensive experimental conditions (high dosage of Ca(ClO)(2) and prolonged oxidation time)."( Treatment of biologically treated leachate by oxidation and coagulation.
Qi, JY; Zhang, HY; Zhao, YC, 2011
)
0.37
" A cost-benefit analysis showed that relative to dosing FFS and disposing waterworks sludge to land, the 20 year WLC was halved by transporting acidified or unacidified sludge up to 80 km for reuse in wastewater treatment."( Acidified and ultrafiltered recovered coagulants from water treatment works sludge for removal of phosphorus from wastewater.
Jarvis, P; Judd, SJ; Keeley, J; Smith, AD, 2016
)
0.43
" Wooden activated carbon was chosen as adsorbent at the dosage of 10 g/L as a primary treatment, and 1500 mg/L polymeric magnesium ferric sulfate was used in coagulation."( Research of combined adsorption-coagulation process in treating petroleum refinery effluent.
He, M; Ren, H; Shui, Y; Wang, B, 2017
)
0.66
" It consists of a silicone nipple shield device and a dosage form containing a therapeutic (or Active Pharmaceutical Ingredient (API)) to enable delivery during breastfeeding."( Iron delivery from liquid-core hydrogels within a therapeutic nipple shield.
Fruk, L; Kerbs, A; Maier, T; Slater, NKH, 2019
)
0.51
" However, the common method of using polyferric sulfate (PFS) and polyacrylamide (PAM) requires a large amount of dosage and produces high iron ion content in the filtrate."( Combined conditioning of inorganic coagulant and polyamine to improve the dewaterability of municipal sludge, minimize dosage and reduce the influence of filtrate.
Hua, B; Li, F; Zhao, S, 2023
)
1.18
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
catalystA substance that increases the rate of a reaction without modifying the overall standard Gibbs energy change in the reaction.
mordantSubstance used to set dyes on fabrics or tissue sections by forming a coordination complex with the dye which then attaches to the fabric or tissue.
astringentA compound that causes the contraction of body tissues, typically used to reduce bleeding from minor abrasions.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
metal sulfateSulfate salts where the cation is a metal ion.
iron molecular entity
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (377)

TimeframeStudies, This Drug (%)All Drugs %
pre-199035 (9.28)18.7374
1990's54 (14.32)18.2507
2000's154 (40.85)29.6817
2010's111 (29.44)24.3611
2020's23 (6.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.20 (24.57)
Research Supply Index6.12 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index115.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (67.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials41 (9.88%)5.53%
Reviews19 (4.58%)6.00%
Case Studies4 (0.96%)4.05%
Observational0 (0.00%)0.25%
Other351 (84.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]